Literature DB >> 18951939

Murine antibody responses following systemic or mucosal immunization with viable or inactivated Vibrio cholerae.

Erik Nygren1, Jan Holmgren, Stephen R Attridge.   

Abstract

Protocols are described for the induction of strong, consistent serum and mucosal antibody responses to Vibrio cholerae O1 or O139 lipopolysaccharide (LPS) following intranasal or oral immunization of adult mice with viable or formalin-killed bacteria. A simplified two-dose schedule for intranasal immunization has been identified, whereby viable bacteria elicit strong serum responses and, most importantly, also induce significant, sustained intestinal IgA responses. Using higher doses of bacteria it was also possible to generate consistently high intestinal and serum anti-LPS responses by the oral route. The efficacy of these immunization schedules was not dependent on co-administration of adjuvant. Gut responses were estimated using two sampling techniques involving the collection of fresh faecal pellets or the preparation of intestinal tissue extracts. The significant correlation between these estimates validates the more convenient approach of measuring intestinal responses using faecal pellet extracts, which allows repeated sampling from the same animals. V. cholerae O1 and O139 were similarly immunogenic by either mucosal route. More intensive immunization schedules for administration of formalin-killed bacteria have also been defined. Using these regimes it was possible to generate serum and gut antibody responses comparable to those elicited by viable V. cholerae. The established immunization protocols will allow evaluation of the systemic and mucosal immunogenicity of new vaccine formulations.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18951939     DOI: 10.1016/j.vaccine.2008.10.011

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  10 in total

Review 1.  Principles of antidote pharmacology: an update on prophylaxis, post-exposure treatment recommendations and research initiatives for biological agents.

Authors:  S Ramasamy; C Q Liu; H Tran; A Gubala; P Gauci; J McAllister; T Vo
Journal:  Br J Pharmacol       Date:  2010-10       Impact factor: 8.739

2.  Mucosal immunization with Vibrio cholerae outer membrane vesicles provides maternal protection mediated by antilipopolysaccharide antibodies that inhibit bacterial motility.

Authors:  Anne L Bishop; Stefan Schild; Bharathi Patimalla; Brian Klein; Andrew Camilli
Journal:  Infect Immun       Date:  2010-08-02       Impact factor: 3.441

Review 3.  Vibrio cholerae: lessons for mucosal vaccine design.

Authors:  Anne L Bishop; Andrew Camilli
Journal:  Expert Rev Vaccines       Date:  2011-01       Impact factor: 5.217

4.  A subset of follicular helper-like MAIT cells can provide B cell help and support antibody production in the mucosa.

Authors:  Owen Jensen; Shubhanshi Trivedi; Jeremy D Meier; Keke C Fairfax; J Scott Hale; Daniel T Leung
Journal:  Sci Immunol       Date:  2022-01-14

5.  Immunogenic Potency of Formalin and Heat Inactivated E. coli O157:H7 in Mouse Model Administered by Different Routes.

Authors:  Nasim Arshadi; Seyed Latif Mousavi; Jafar Amani; Shahram Nazarian
Journal:  Avicenna J Med Biotechnol       Date:  2020 Jul-Sep

6.  Establishment of an adult mouse model for direct evaluation of the efficacy of vaccines against Vibrio cholerae.

Authors:  E Nygren; B-L Li; J Holmgren; S R Attridge
Journal:  Infect Immun       Date:  2009-05-26       Impact factor: 3.441

7.  PCEP enhances IgA mucosal immune responses in mice following different immunization routes with influenza virus antigens.

Authors:  Nelson F Eng; Srinivas Garlapati; Volker Gerdts; Lorne A Babiuk; George K Mutwiri
Journal:  J Immune Based Ther Vaccines       Date:  2010-08-24

8.  Use of a MAIT-Activating Ligand, 5-OP-RU, as a Mucosal Adjuvant in a Murine Model of Vibrio cholerae O1 Vaccination.

Authors:  Owen Jensen; Shubhanshi Trivedi; Kelin Li; Jeffrey Aubé; J Scott Hale; Edward T Ryan; Daniel T Leung
Journal:  Pathog Immun       Date:  2022-08-24

9.  Fecal antibody levels as a noninvasive method for measuring immunity to gastrointestinal nematodes in ecological studies.

Authors:  Kathryn A Watt; Daniel H Nussey; Rachel Maclellan; Jill G Pilkington; Tom N McNeilly
Journal:  Ecol Evol       Date:  2015-12-08       Impact factor: 2.912

10.  A dysbiotic gut microbiome suppresses antibody mediated-protection against Vibrio cholerae.

Authors:  John C Macbeth; Rui Liu; Salma Alavi; Ansel Hsiao
Journal:  iScience       Date:  2021-11-14
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.